DIRS.INFO The most relevant business & tech news

☆ 'Ozempic face' could create a huge market for fillers. One newly-public company wants to cash in.
▼ + stars: | 2024-04-25 | by ( Geoff Weiss | Julia Pugachevsky | ) www.businessinsider.com time to read: +1 min

Its CEO told Bloomberg that weight-loss drugs could boost its fillers business. Ozempic face is a result of aging and rapid weight loss, one cosmetic dermatologist said. NEW LOOK Sign up to get the inside scoop on today’s biggest stories in markets, tech, and business — delivered daily. AdvertisementThe CEO of Swiss pharmaceutical giant Galderma thinks the popularity of weight-loss drugs like Ozempic could boost its facial fillers business. That's because Ozempic can result in a sunken-in look in some patients' faces, Galderma CEO Flemming Ornskov told Bloomberg — an effect he said fillers can help counteract.

Persons: —, Flemming Ornskov, Flemming Organizations: Swiss pharma, Bloomberg, Service, Business Locations: Swiss

☆ Counterfeit Botox has been found in several states. Here’s what consumers should know.
▼ + stars: | 2024-04-16 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +11 min

CNN —The US Food and Drug Administration is warning that dangerous counterfeit versions of Botox have been identified in multiple states, putting the safety of consumers at risk. The incidents of counterfeit Botox being administered to consumers appear to be connected to products that have been purchased from unlicensed sources and then administered by either unlicensed or licensed providers. The counterfeit Botox products may be identified by the lot number C3709C3 found on the outer carton and vial, the FDA said. Counterfeit botox has been found in several states. Most often, when counterfeit Botox is sold, “the injector knows they’re purchasing something counterfeit,” Sung said.

Persons: Washington –, Botox, Lavanya Krishnan, Arya Derm, ” Krishnan, Krishnan, Allergan, ”, “, Jimmy Sung, you’re, can’t, ” Sung, Michael Cameron, Cameron, ” Cameron, Sung, “ I’m, I’ve, Steven Williams, ” Williams, Dr, Sanjay Gupta, Cynthia Elliott, ” Elliott Organizations: CNN, Food and Drug Administration, FDA, US Centers for Disease Control, CDC, American Board of Cosmetic, Revance Therapeutics, Merz Aesthetics, Tribeca Aesthetics, Cameron Dermatology, Mount Sinai Health, American Society of Plastic Surgeons, “, CNN Health Locations: – Colorado, Florida , Illinois , Kentucky , Nebraska , New Jersey , New York , Tennessee, San Francisco, United States, New York City, New York, Florida

☆ Galderma CEO says it's an 'excellent time' for Swiss IPO
▼ + stars: | 2024-03-06 | by ( ) www.cnbc.com time to read: 1 min

Share Share Article via Facebook Share Article via Twitter Share Article via LinkedIn Share Article via EmailGalderma CEO says it's an 'excellent time' for Swiss IPOFlemming Ørnskov, CEO of Galderma, says its initial public offering in Switzerland is the "next natural step" for the dermatology company.

Persons: it's, Flemming Ørnskov Organizations: Swiss Locations: Switzerland

☆ Cetaphil's Taylor Swift-themed Super Bowl ad is getting praise online, but a TikTok creator says it's a rip-off
▼ + stars: | 2024-02-11 | by ( Lauren Edmonds | ) www.businessinsider.com time to read: +5 min

Cetaphil debuted a Taylor Swift-themed ad for Super Bowl LVIII. AdvertisementA daughter and her stepfather have accused skincare brand Cetaphil of copying their TikTok videos to create a Taylor Swift-inspired Super Bowl commercial. The drama around the ad began on Friday when the company first shared its Super Bowl LVIII commercial. AdvertisementOn Sunday, the San Francisco 49ers and the Kansas City Chiefs will face off in Super Bowl LVIII at Allegiant Stadium in Las Vegas. Click here to learn how to watch Super Bowl LVIII in the United States or abroad.

Persons: Cetaphil, Taylor Swift, Sharon Mbabazi, —, Travis Kelce, they've, Swifties, y'all, Mbabazi, Swift, Cetaphil's, Craig Elimeliah, Clio Organizations: Service, NFL, Kansas City Chiefs, YouTube, Super, Cetaphil, Galderma, Business, San Francisco 49ers Locations: Allegiant, Las Vegas, United States

☆ Beauty brands are combining AI and 3D-printing tech to make personalized skincare products that target your specific needs
▼ + stars: | 2023-11-15 | by ( Bella Sayegh | ) www.businessinsider.com time to read: +9 min

Personalized skincare represents one of the fastest growing segments of the beauty and wellness industry. "Personalized products for skincare are more beneficial," said Melissa Snover, the founder and CEO of Nourished , a nutrition company. Rem3dy Health GroupNourished partnered with Neutrogena earlier this year to create personalized skincare supplements, called Skinstacks. NeutrogenaMore companies are leaning into custom skincareCompanies that sell more generalized skincare products are hopping on the personalization trend. Cetaphil, a brand popular for its sensitive skincare line, launched its skincare digital-assistant tool and AI skin analysis in March.

Persons: —, doesn't, Melissa Snover, Snover, Logan McGill, Johnson, McGill, Silvina Nordenstohl, Nordenstahl, Galderma, dermatologists, Scott Walker, TikTok, Aaron Lucy, Walker Organizations: Service, Grand View Research, Rem3dy, Johnson, Companies, Tech Locations: McGill, Denver, skincare

☆ Europe’s listless IPOs are red flag for big floats
▼ + stars: | 2023-07-31 | by ( Pamela Barbaglia | ) www.reuters.com time to read: +4 min

And so far, the performance of the floats that have got away has been relatively poor. It’s a major red flag for larger IPO candidates, like CVC Capital Partners or EQT’s (EQTAB.ST) Galderma. Only 65 companies decided to brave choppy stock markets in Europe, raising $6.6 billion in overall proceeds, according to Dealogic data. Italian betting group Lottomatica (LTMC.MI) and German web-hosting company IONOS (IOSn.DE) priced at the bottom of their initial ranges. Dealogic data shows that IPOs in the region raised a total of $6.6 billion between the start of 2023 and July 20.

Persons: Breakingviews, Thyssenkrupp, Nucera, Hidroelectrica, Liam Proud, Oliver Taslic Organizations: Reuters, Capital Partners, underwriters, Bankers, Swiss, Reuters Graphics Reuters, Thomson Locations: Europe, Romanian, Saudi, Swedish

Despite a rebound in fundraising and block trading activity, year-to-date IPO volumes came in at their lowest level since 2019. Equity capital markets (ECM) advisers, however, are optimistic of a recovery in listing activity in the latter part of the year. In the United States, IPO volumes jumped more than 50% from the fourth quarter of 2022, but were still 11% down from the same period last year. IPOs briefly flickered back to life in February, as companies including solar tech firm Nextracker (NXT.O) and Chinese sensor maker Hesai Group (HSAI.O) pushed ahead with their listings. RECOVERY DELAYEDIn Europe, investment bankers said the market volatility spurred by the banking crisis is likely to affect the pipeline of deals.

☆ Galderma owners delay IPO, review Credit Suisse role - source
▼ + stars: | 2023-03-29 | by ( ) www.reuters.com time to read: +1 min

The shareholders, including Swedish buyout house EQT (EQTAB.ST) and the Abu Dhabi Investment Authority (ADIA), are also reviewing Credit Suisse's (CSGN.S) role as global coordinator for the IPO, the source added, after the troubled lender agreed to be taken over by rival UBS in a government-brokered rescue. Bloomberg first reported on the IPO delay and the review of Credit Suisse's role. Galderma had been preparing to list as soon as after the Easter holidays, sources had told Reuters, having previously delayed its IPO plans because of poor market conditions. Last year, the group was forced to postpone its listing ambitions after the invasion of Ukraine and soaring interest rates ground the IPO market almost to a halt, as reported. Galderma and Credit Suisse declined to comment.

☆ Bankers not expecting quick recovery as IPO volumes plunge to lowest level since 2008
▼ + stars: | 2022-12-20 | by ( Pablo Mayo Cerqueiro | Echo Wang | ) www.reuters.com time to read: +5 min

With questions swirling around monetary policy and the prospect of a looming recession, IPO advisers are not holding their breath on a near-term recovery in the equity capital markets. Global share sales plunged this year as the IPO market froze and hundreds of companies postponed stock market debuts, as Russia's invasion of Ukraine and interest rate hikes from central banks weighed on the broader economy. “It’s all about rates - the price of money changed and it has affected everything," said James Palmer, head of EMEA equity capital markets (ECM) at Bank of America. A return by long-only investors to capital markets deals is seen as key for any recovery, after a year in which hedge funds have taken a lead role as buyers of new issuance. "When the stock market is going like this, people typically don't buy new issuance," said Joshua Bonnie, co-head of Simpson Thacher & Bartlett's global capital markets practice.

As market volatility persists amid Europe's energy crisis and worsening economic forecasts, companies are holding off on their plans to go public. Register now for FREE unlimited access to Reuters.com Register"One transaction alone cannot re-open the floodgates of IPO executions. This requires more predictable macro and reduced equity market volatility," said Antoine de Guillenchmidt, co-head of EMEA Equity Capital Markets at Goldman Sachs. Going forward, as interest rates continue to rise and companies look for financially efficient ways of refinancing their balance sheets, equity capital markets are likely to see a surge in convertible bond activity. "We will see many more convertibles and mandatory convertible instruments because some issuers don't have many alternatives, and investors are still very keen," said Andreas Bernstorff, head of equity capital markets at BNP Paribas.

☆ Оксфордский университет тестирует препарат, который можно использовать для лечения COVID-19
▼ + stars: | 2021-06-25 | by ( Mld Media Srl | ) noi.md time to read: +4 min

Оксфордский университет 23 июня сообщил о намерении провести клиническое исследование (КИ) антипаразитарного препарата ивермектина. Исследование будет поддержано британским правительством, оно направлено на определение способов лечения коронавирусной инфекции в амбулаторных условиях. Для лечения коронавирусной инфекции ивермектин уже используется в Индии, но в ВОЗ не рекомендуют применять этот препарат по такому показанию. Ранее Всемирная организация здравоохранения и Управление по контролю за продуктами и лекарствами США не рекомендовали использовать ивермектин для лечения от COVID-19, но, например, в Индии препарат по этому показанию применяется. Также проводилось исследование, в котором оценивалась эффективность и безопасность ивермектина у пациентов с лихорадкой Денге, в лечении этого заболевания препарат оказался неэффективен.

Persons: –, Крис Батлер, Вильям Кэмбелл, Сатоси Омура Organizations: Оксфордский университет, КИ, ВОЗ, Всемирная организация здравоохранения, Управление по контролю за продуктами, КИ Оксфордский университет, Университет штата Колорадо, Американское общество тропической медицины и гигиены Locations: Индия, США, Россия, Япония, Ирландия

Search resuls for: "Galderma"

11 mentions found